Skip to main content

Table 2 Epidemiological results of the model from 2020 to 2040 with both alternatives

From: Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain

Year

Control

Intervention

Dementia incidence

Dementia prevalence

Dementia incidence

Dementia prevalence

2020

948

435

672

291

2021

2017

1779

1505

1239

2022

2939

3850

2234

2766

2023

3853

6572

3099

4818

2024

4623

9503

3692

7177

2025

5328

12,503

4217

9608

2026

5721

15,209

4709

11,933

2027

6043

17,532

4953

13,946

2028

6297

19,420

5239

15,661

2029

6539

20,865

5417

17,053

2030

6786

22,220

5779

18,280

2031

7032

23,424

5851

19,518

2032

6999

24,427

6087

20,457

2033

7370

25,320

6228

21,339

2034

7401

26,075

6525

22,186

2035

7956

26,958

6665

23,075

2036

6686

27,289

6093

23504

2037

5337

26,168

5104

22,953

2038

4279

23,961

4064

21,465

2039

3183

21,013

3278

19,341

2040

2161

17,659

2485

16,801